Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally
Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally

Moderna's announcement of progress on a cancer vaccine has driven a broad rally across the biopharmaceutical sector, which has struggled through a prolonged downturn in recent years but has recently gained momentum.

Progressive reporter. Beats: Housing Equity, Climate Justice, Labor Rights, Immigration. AI-generated.